# US 2025/0146939 A1 · Sers nano-particle, preparation method therefor, and application thereof to method for distinguishing ctcs from wbcs

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0146939 A1
- Document ID: US20250146939A1
- Status: Published application
- Kind: A1
- Application number: 18/838,080
- Filed: 2023-02-15
- Published: 2025-05-08
- Earliest claimed: 2022-02-16
- Assignees: Ningbo Cixi Institute of BioMedical Engineering; Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences; Zhejiang Cancer Hospital
- Applicants: Ningbo Cixi Institute of Biomedical Engineering; Ningbo Institute of Materials Technology and Engineering, Chinese Academy of Sciences; Zhejiang Cancer Hospital
- Inventors: Aiguo WU; Jie LIN; Dinghu Zhang; Xiaoxia WU; Guoliang SHAO
- Web page: https://patentgrep.com/patent/US20250146939A1

## CPC

- G01N 21/6486: {Measuring fluorescence of biological material, e.g. DNA, RNA, cells (G01N21/6428 takes precedence)}
- C07K 16/30: from tumour cells
- G01N 33/56972: {White blood cells}
- G01N 33/575: for cancer
- G01N 21/658: {enhancement Raman, e.g. surface plasmons}
- G01N 2201/129: Using chemometrical methods
- G01N 2333/705: Assays involving receptors, cell surface antigens or cell surface determinants
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

Disclosed are a SERS nano-particle, a preparation method therefor, and an application thereof to a method for distinguishing CTCs from WBCs. The SERS nano-particle are formed by core magnetic particles, noble metal nano-particles, Raman signal molecules, hydrophilic molecules and target molecules. A method for distinguishing CTCs from WBCs comprises: enabling a SERS nano-particle to make contact with a to-be-detected solution containing CTCs and/or WBCs; performing incubation; then detecting SERS signal intensity of a cell combined with the SERS nano-particle; setting SERS signal intensity threshold; if SERS signal intensity of the cell combined with the SERS nano-particle exceeds SERS signal intensity threshold, determining the cell as CTS; otherwise, determining the cell as WBC. A ROC curve is used for the first time to assist the SERS technique in distinguishing CTCs from WBCs.

## Claims

### Claim 1

(canceled)

### Claim 2

(canceled)

### Claim 3

A SERS nano-particle, wherein the SERS nano-particle sequentially comprises, from inside to outside, core particles, a noble metal nano-particle layer, a Raman signal molecular layer, a high molecular layer and a target antibody anti-trop2 layer;
the core particles are magnetic particles, surfaces of which are provided with a positive-charge polymer modifying layer;
the noble metal nano-particle layer is layered structure formed by noble metal nano-particles assembled on the surfaces of the core particles by means of electrostatic interaction;
the Raman signal molecular layer is a layered structure formed by Raman signal molecules connected to a surface of the noble metal nano-particle layer;
the high molecular layer is a layered structure formed by hydrophilic molecules wrapping a surface of the Raman signal molecular layer;
the target antibody anti-trop2 layer is a layered structure formed by a target antibody anti-trop2 coupled to an outer surface of the high molecular layer.

### Claim 4 (depends on 3)

The SERS nano-particle according to claim 3, wherein a particle size of the core particles is 10-1000 nm, a particle size of the noble metal nano-particles is 1-100 nm, and a particle size of the SERS nano-particle is 100-1000 nm.

### Claim 5 (depends on 3)

A preparation method for the SERS nano-particle according to claim 3, comprising the following steps:
(S1) obtaining core particles;
(S2) assembling noble metal nano-particles on surfaces of the core particles by means of electrostatic interaction to form a noble metal nano-particle layer to obtain a particle I;
(S3) connecting Raman signal molecules to a surface of the noble metal nano-particle layer to form a Raman signal molecular layer to obtain a particle II;
(S4) wrapping a surface of the Raman signal molecular layer with hydrophilic molecules to form a high molecular layer to obtain a particle III; and
(S5) coupling an antibody anti-trop2 to a surface of the high molecular layer to form a target antibody anti-trop2 layer to obtain a magnetic SERS nano-particle.

### Claim 6 (depends on 5)

The preparation method according to claim 5, wherein in (S1), the core particles are obtained by a reaction I of a solution containing a magnetic metal salt, an alkaline substance, a positive-charge polymer and a solvent I.
in (S2), a noble metal nano-particle solution and a core particle solution are mixed, and then stirring I is performed to obtain the particle I;
in (S3), a Raman signal molecule solution and a particle I solution are mixed, and then stirring II is performed to obtain the particle II;
in (S4), a particle II solution and CH3CH2OH, NH3·H2O are mixed, stirring III is performed, and a polydopamine solution is added for a reaction III to obtain the particle III;
in (S5), the SERS nano-particle is obtained by stirring IV of a solution containing the particle III, a buffer solution and a target antibody anti-trop2.

### Claim 7 (depends on 6)

The preparation method according to claim 6, wherein in (S1), the magnetic metal salt comprises a magnetic metal chloride, the alkaline substance comprises CH3COONa, the positive-charge polymer comprises polyetherimide, the solvent I comprises glycol, and conditions for the reaction I are as follows: a time for the reaction I is 1-10 hrs, and a temperature for the reaction I is 100-500° C.;
in (S2), a time for the stirring I is 10-120 min;
in (S3), a time for the stirring II is 1-10 hrs;
in (S4), a time for the stirring III is 1-100 min, and a time for the reaction III is 1-10 hrs;
in (S5), the buffer solution comprises at least one selected from a Tris-HCl solution and an ammonia alkaline solution, a time for the stirring IV is 1 h-72 hrs, and a temperature for the stirring IV is 15-40° C.

### Claim 8 (depends on 3)

A method for distinguishing CTCs from WBCs for a non-diagnostic purpose, comprising: enabling the SERS nano-particle according to claim 3 to make contact with a to-be-detected solution containing CTCs and/or WBCs; performing incubation; then detecting a SERS signal intensity of a cell combined with the SERS nano-particle; setting a SERS signal intensity threshold; if the SERS signal intensity of the cell combined with the SERS nano-particle exceeds the SERS signal intensity threshold, determining the cell as a CTS; otherwise, determining the cell as a WBC.

### Claim 9 (depends on 8)

The method for distinguishing CTCs from WBCs for a non-diagnostic purpose according to claim 8, wherein the SERS signal intensity threshold is a point value within a fluorescence intensity of 0-3000a.u.

### Claim 10 (depends on 8)

The method for distinguishing CTCs from WBCs for a non-diagnostic purpose according to claim 8, wherein the SERS signal intensity threshold is determined according to a ROC curve of SERS intensities of CTCs and WBCs in known samples.

### Claim 11 (depends on 8)

The method for distinguishing CTCs from WBCs for a non-diagnostic purpose according to claim 8, wherein SERS intensities of CTCs and WBCs in known samples are input to a SPSS, and the SERS signal intensity threshold is obtained after analysis of a ROC curve.

### Claim 12

A system for distinguishing CTCs from WBCs for a non-diagnostic purpose, comprising:
a sample loading module, used for collecting and/or storing samples, wherein the samples comprise known samples formed by certain CTCs and WBCs and/or to-be-detected samples formed by uncertain CTCs and WBCs;
a ROC curve construction module, used for detecting SERS signal intensities of the known samples, plotting an ROC curve of specificity and sensitivity, and outputting a recommended threshold according to detection requirements; and
a detection module, used for detecting SERS signal intensities of the to-be-detected samples and outputting a detection result identifier according to the set threshold.

### Claim 13 (depends on 3)

The SERS nano-particle according to claim 3, wherein a positive-charge polymer in the positive-charge polymer modifying layer comprises polyetherimide.

### Claim 14 (depends on 3)

The SERS nano-particle according to claim 3, wherein the magnetic particles comprise at least one selected from Fe nano-particles, FeO nano-particles and Fe3O4 nano-particles;
the noble metal nano-particles comprise at least one selected from gold nano-particles, silver nano-particles, platinum nano-particles and nano-copper particles;
the Raman signal molecules comprise at least one selected from 4-mercaptobenzoic acid, mercaptopyridine, 4-aminothiophenol, naphthalenethiol, 4-fluorothiophenol, rhodamine, crystal violet, alizarin red and Nile blue;
the hydrophilic molecules comprise at least one selected from polydopamine, bovine serum albumin and polyethylene glycol.

### Claim 15 (depends on 11)

The method for distinguishing CTCs from WBCs for a non-diagnostic purpose according to claim 11, wherein SERS intensities of CTCs and WBCs in known samples are input to a SPSS to plot a ROC curve, a series of cut-off values corresponding to different sensitivities and specificities are obtained after the ROC curve is analyzed, and a cut-off value corresponding to a maximum specificity and sensitivity is the SERS signal intensity threshold.
